Tag: Clinical Research

Rethinking the Cost-Benefit of PSA Tests

Was this Fixing U.S. Healthcare blog wrong to single out PSA as not worth its cost? This was the claim in two previous posts, including the overall most popular one, The Problem of Diminishing Marginal Benefit in Healthcare. Some new information suggests that we need to rethink that original claim. Prostate Specific Antigen Since prostate … Continue reading Rethinking the Cost-Benefit of PSA Tests →

Reforming U.S. Healthcare: Even Research Statistics Are Rigged

To paraphrase Elizabeth Barrett Browning, How do I rig thee? Let me count the ways. Even research statistics are all too often rigged, according to a commentary in this month’s Journal of the A.M.A.  These rigged statistics are being applied to clinical studies of new drugs, devices, and treatments to put them just far enough … Continue reading Reforming U.S. Healthcare: Even Research Statistics Are Rigged →